Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours

Background: A number of developments have been made in computerized patient data management systems (PDMSs), making them of interest to medical and nursing staff as a means of improving patient care. Objectives: The aim of this study was to assess the capability of a PDMS to record and provide drug-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2004-06, Vol.26 (6), p.915-924
Hauptverfasser: Hartmann, Bernd, Junger, Axel, Brammen, Dominik, Röhrig, Rainer, Klasen, Joachim, Quinzio, Lorenzo, Benson, Matthias, Hempelmann, Gunter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 924
container_issue 6
container_start_page 915
container_title Clinical therapeutics
container_volume 26
creator Hartmann, Bernd
Junger, Axel
Brammen, Dominik
Röhrig, Rainer
Klasen, Joachim
Quinzio, Lorenzo
Benson, Matthias
Hempelmann, Gunter
description Background: A number of developments have been made in computerized patient data management systems (PDMSs), making them of interest to medical and nursing staff as a means of improving patient care. Objectives: The aim of this study was to assess the capability of a PDMS to record and provide drug-administration data and to investigate whether the PDMS may be used as a means of support for clinical audits and quality control. Furthermore, we assessed whether antibiotic therapy as a surrogate for infections correlates with hospital mortality in patients staying >24 hours in a surgical intensive care unit (SICU). Methods: Because of its medical and economic importance in ICU treatment, we chose to use the field of antibiotic therapy as an example. A PDMS was used in a 14-bed SICU (Department of Anesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Giessen, Giessen, Germany) to record relevant patient data, including therapeutic, diagnostic, and nursing actions. During a 15-month period (April 1, 2000 to June 30, 2001), antibiotic drug therapy was electronically analyzed and presented using the anatomic therapeutic chemical (ATC) category for antibacterials (ATC group, J01) with daily defined doses. Furthermore, the correlation of antibiotic therapy with patient outcome (hospital mortality) was tested using logistic regression analysis. Results: A total of 2053 patients were treated in the SICU. Of these, 58.0% (1190 patients) received antibiotics (4479 treatment days; 13,145 single doses). Cephalosporins (ATC category, J01DA) were used most frequently (1785 treatment days [39.9% of treatment days]), followed by combinations of penicillins with beta-lactam inhibitors (ATC category, J01CR; 1478 treatment days [33.0%]) and imidazole derivatives (ATC category, J01XD; 667 treatment days [14.9%]). The antibiotic therapy lasted 1 week. A total of 36.7% of cases were treated with only 1 antibiotic agent, 14.1% were given a combination of 2, and 7.2% were given a combination of ≥3 antibiotic agents. Seven hundred twenty-six patients remained in the SICU for >24 hours; 143 (19.7%) died during their hospital stay; 110 (15.2%) in the SICU. The duration of antibiotic therapy (odds ratio [OR], 1.46) and number of different antibiotic drugs used (OR, 2.15) significantly correlated with hospital mortality. Conclusions: Antibiotic therapy in a SICU can be assessed and analyzed in de
doi_str_mv 10.1016/S0149-2918(04)90135-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66720494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S014929180490135X</els_id><sourcerecordid>66720494</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-6e36a3c146a5a0bab9e723386d34bc8e9238bb3ab7061b4656723a9a2ee023383</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTjv6CEpAEF2U5q_SFTcijT8DI4I60LtwK3W7O0NVpU1SDv1GPqap6cYBN65CuN85NzmHkKecveaM6zffGVemEoY3L5l6ZRiXdbW-Rxa8WZqKc7W-TxZ_kTPyKKVrxpg0tXhIzngttFBaLMjvb_jL4w0NGwpj9q0P2TvaxWlLp4TUjxRomuLWO-jpxerqLf0CI2xxwDHTG593Zb6H7OdrBxnocDdOh5RxoJsQKXSdzz6MxSRM2YUByzroD8mnecfJIdGU4eDHLR1CRJp3MFKh6C5MMT0mDzbQJ3xyOs_J1ccPP1afq8uvny5W7y8rpxTPlUapQTquNNTAWmgNLoWUje6kal2DRsimbSW0S6Z5q3StyxgMCEQ2c_KcvDj67mP4OWHKdvDJYd_DiGFKVhcBU0YV8Pk_4HV5Z_lUspzJkropCReqPlIuhpQibuw--gHioUB2LtLeFmnnlixT9rZIuy66Zyf3qR2wu1OdmivAuyOAJYxSYbTJlQwddj6iy7YL_j8r_gCC5K8_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1032919246</pqid></control><display><type>article</type><title>Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Hartmann, Bernd ; Junger, Axel ; Brammen, Dominik ; Röhrig, Rainer ; Klasen, Joachim ; Quinzio, Lorenzo ; Benson, Matthias ; Hempelmann, Gunter</creator><creatorcontrib>Hartmann, Bernd ; Junger, Axel ; Brammen, Dominik ; Röhrig, Rainer ; Klasen, Joachim ; Quinzio, Lorenzo ; Benson, Matthias ; Hempelmann, Gunter</creatorcontrib><description>Background: A number of developments have been made in computerized patient data management systems (PDMSs), making them of interest to medical and nursing staff as a means of improving patient care. Objectives: The aim of this study was to assess the capability of a PDMS to record and provide drug-administration data and to investigate whether the PDMS may be used as a means of support for clinical audits and quality control. Furthermore, we assessed whether antibiotic therapy as a surrogate for infections correlates with hospital mortality in patients staying &gt;24 hours in a surgical intensive care unit (SICU). Methods: Because of its medical and economic importance in ICU treatment, we chose to use the field of antibiotic therapy as an example. A PDMS was used in a 14-bed SICU (Department of Anesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Giessen, Giessen, Germany) to record relevant patient data, including therapeutic, diagnostic, and nursing actions. During a 15-month period (April 1, 2000 to June 30, 2001), antibiotic drug therapy was electronically analyzed and presented using the anatomic therapeutic chemical (ATC) category for antibacterials (ATC group, J01) with daily defined doses. Furthermore, the correlation of antibiotic therapy with patient outcome (hospital mortality) was tested using logistic regression analysis. Results: A total of 2053 patients were treated in the SICU. Of these, 58.0% (1190 patients) received antibiotics (4479 treatment days; 13,145 single doses). Cephalosporins (ATC category, J01DA) were used most frequently (1785 treatment days [39.9% of treatment days]), followed by combinations of penicillins with beta-lactam inhibitors (ATC category, J01CR; 1478 treatment days [33.0%]) and imidazole derivatives (ATC category, J01XD; 667 treatment days [14.9%]). The antibiotic therapy lasted &lt;3 days in 65.6% of cases. In 13.8% of cases, the treatment lasted &gt;1 week. A total of 36.7% of cases were treated with only 1 antibiotic agent, 14.1% were given a combination of 2, and 7.2% were given a combination of ≥3 antibiotic agents. Seven hundred twenty-six patients remained in the SICU for &gt;24 hours; 143 (19.7%) died during their hospital stay; 110 (15.2%) in the SICU. The duration of antibiotic therapy (odds ratio [OR], 1.46) and number of different antibiotic drugs used (OR, 2.15) significantly correlated with hospital mortality. Conclusions: Antibiotic therapy in a SICU can be assessed and analyzed in detail using a PDMS. Furthermore, in this study, the duration of antibiotic therapy and the number of antibiotic agents used correlated with hospital mortality. In further developing PDMSs, it is important for quality-assurance purposes to document the reasons for giving antibiotics and for changing prescriptions. It would also be helpful to integrate certain therapy standards and reminder functions for the duration of therapy in the PDMS.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/S0149-2918(04)90135-X</identifier><identifier>PMID: 15262462</identifier><language>eng</language><publisher>United States: EM Inc USA</publisher><subject>Adult ; Anti-Bacterial Agents - classification ; Anti-Bacterial Agents - therapeutic use ; antibiotics ; Bacterial Infections - drug therapy ; Bacterial Infections - mortality ; Bacterial Infections - prevention &amp; control ; computerized patient record ; critical care ; drug therapy ; Drug Utilization Review - statistics &amp; numerical data ; Female ; Germany - epidemiology ; Hospital Information Systems ; Hospital Mortality ; Hospitals, University - standards ; Humans ; intensive care ; Intensive Care Units - standards ; Length of Stay - statistics &amp; numerical data ; Logistic Models ; Male ; Medical Records Systems, Computerized ; Odds Ratio ; Outcome and Process Assessment (Health Care) - statistics &amp; numerical data ; ROC Curve ; Surgical Procedures, Operative - mortality ; Surgical Procedures, Operative - standards ; Surgical Wound Infection - drug therapy ; Surgical Wound Infection - mortality ; Surgical Wound Infection - prevention &amp; control ; Treatment Outcome</subject><ispartof>Clinical therapeutics, 2004-06, Vol.26 (6), p.915-924</ispartof><rights>2004</rights><rights>Copyright Elsevier Limited Jun 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-6e36a3c146a5a0bab9e723386d34bc8e9238bb3ab7061b4656723a9a2ee023383</citedby><cites>FETCH-LOGICAL-c441t-6e36a3c146a5a0bab9e723386d34bc8e9238bb3ab7061b4656723a9a2ee023383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1032919246?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15262462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hartmann, Bernd</creatorcontrib><creatorcontrib>Junger, Axel</creatorcontrib><creatorcontrib>Brammen, Dominik</creatorcontrib><creatorcontrib>Röhrig, Rainer</creatorcontrib><creatorcontrib>Klasen, Joachim</creatorcontrib><creatorcontrib>Quinzio, Lorenzo</creatorcontrib><creatorcontrib>Benson, Matthias</creatorcontrib><creatorcontrib>Hempelmann, Gunter</creatorcontrib><title>Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours</title><title>Clinical therapeutics</title><addtitle>Clin Ther</addtitle><description>Background: A number of developments have been made in computerized patient data management systems (PDMSs), making them of interest to medical and nursing staff as a means of improving patient care. Objectives: The aim of this study was to assess the capability of a PDMS to record and provide drug-administration data and to investigate whether the PDMS may be used as a means of support for clinical audits and quality control. Furthermore, we assessed whether antibiotic therapy as a surrogate for infections correlates with hospital mortality in patients staying &gt;24 hours in a surgical intensive care unit (SICU). Methods: Because of its medical and economic importance in ICU treatment, we chose to use the field of antibiotic therapy as an example. A PDMS was used in a 14-bed SICU (Department of Anesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Giessen, Giessen, Germany) to record relevant patient data, including therapeutic, diagnostic, and nursing actions. During a 15-month period (April 1, 2000 to June 30, 2001), antibiotic drug therapy was electronically analyzed and presented using the anatomic therapeutic chemical (ATC) category for antibacterials (ATC group, J01) with daily defined doses. Furthermore, the correlation of antibiotic therapy with patient outcome (hospital mortality) was tested using logistic regression analysis. Results: A total of 2053 patients were treated in the SICU. Of these, 58.0% (1190 patients) received antibiotics (4479 treatment days; 13,145 single doses). Cephalosporins (ATC category, J01DA) were used most frequently (1785 treatment days [39.9% of treatment days]), followed by combinations of penicillins with beta-lactam inhibitors (ATC category, J01CR; 1478 treatment days [33.0%]) and imidazole derivatives (ATC category, J01XD; 667 treatment days [14.9%]). The antibiotic therapy lasted &lt;3 days in 65.6% of cases. In 13.8% of cases, the treatment lasted &gt;1 week. A total of 36.7% of cases were treated with only 1 antibiotic agent, 14.1% were given a combination of 2, and 7.2% were given a combination of ≥3 antibiotic agents. Seven hundred twenty-six patients remained in the SICU for &gt;24 hours; 143 (19.7%) died during their hospital stay; 110 (15.2%) in the SICU. The duration of antibiotic therapy (odds ratio [OR], 1.46) and number of different antibiotic drugs used (OR, 2.15) significantly correlated with hospital mortality. Conclusions: Antibiotic therapy in a SICU can be assessed and analyzed in detail using a PDMS. Furthermore, in this study, the duration of antibiotic therapy and the number of antibiotic agents used correlated with hospital mortality. In further developing PDMSs, it is important for quality-assurance purposes to document the reasons for giving antibiotics and for changing prescriptions. It would also be helpful to integrate certain therapy standards and reminder functions for the duration of therapy in the PDMS.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - classification</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotics</subject><subject>Bacterial Infections - drug therapy</subject><subject>Bacterial Infections - mortality</subject><subject>Bacterial Infections - prevention &amp; control</subject><subject>computerized patient record</subject><subject>critical care</subject><subject>drug therapy</subject><subject>Drug Utilization Review - statistics &amp; numerical data</subject><subject>Female</subject><subject>Germany - epidemiology</subject><subject>Hospital Information Systems</subject><subject>Hospital Mortality</subject><subject>Hospitals, University - standards</subject><subject>Humans</subject><subject>intensive care</subject><subject>Intensive Care Units - standards</subject><subject>Length of Stay - statistics &amp; numerical data</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical Records Systems, Computerized</subject><subject>Odds Ratio</subject><subject>Outcome and Process Assessment (Health Care) - statistics &amp; numerical data</subject><subject>ROC Curve</subject><subject>Surgical Procedures, Operative - mortality</subject><subject>Surgical Procedures, Operative - standards</subject><subject>Surgical Wound Infection - drug therapy</subject><subject>Surgical Wound Infection - mortality</subject><subject>Surgical Wound Infection - prevention &amp; control</subject><subject>Treatment Outcome</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkc2KFDEUhYMoTjv6CEpAEF2U5q_SFTcijT8DI4I60LtwK3W7O0NVpU1SDv1GPqap6cYBN65CuN85NzmHkKecveaM6zffGVemEoY3L5l6ZRiXdbW-Rxa8WZqKc7W-TxZ_kTPyKKVrxpg0tXhIzngttFBaLMjvb_jL4w0NGwpj9q0P2TvaxWlLp4TUjxRomuLWO-jpxerqLf0CI2xxwDHTG593Zb6H7OdrBxnocDdOh5RxoJsQKXSdzz6MxSRM2YUByzroD8mnecfJIdGU4eDHLR1CRJp3MFKh6C5MMT0mDzbQJ3xyOs_J1ccPP1afq8uvny5W7y8rpxTPlUapQTquNNTAWmgNLoWUje6kal2DRsimbSW0S6Z5q3StyxgMCEQ2c_KcvDj67mP4OWHKdvDJYd_DiGFKVhcBU0YV8Pk_4HV5Z_lUspzJkropCReqPlIuhpQibuw--gHioUB2LtLeFmnnlixT9rZIuy66Zyf3qR2wu1OdmivAuyOAJYxSYbTJlQwddj6iy7YL_j8r_gCC5K8_</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Hartmann, Bernd</creator><creator>Junger, Axel</creator><creator>Brammen, Dominik</creator><creator>Röhrig, Rainer</creator><creator>Klasen, Joachim</creator><creator>Quinzio, Lorenzo</creator><creator>Benson, Matthias</creator><creator>Hempelmann, Gunter</creator><general>EM Inc USA</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20040601</creationdate><title>Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours</title><author>Hartmann, Bernd ; Junger, Axel ; Brammen, Dominik ; Röhrig, Rainer ; Klasen, Joachim ; Quinzio, Lorenzo ; Benson, Matthias ; Hempelmann, Gunter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-6e36a3c146a5a0bab9e723386d34bc8e9238bb3ab7061b4656723a9a2ee023383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - classification</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotics</topic><topic>Bacterial Infections - drug therapy</topic><topic>Bacterial Infections - mortality</topic><topic>Bacterial Infections - prevention &amp; control</topic><topic>computerized patient record</topic><topic>critical care</topic><topic>drug therapy</topic><topic>Drug Utilization Review - statistics &amp; numerical data</topic><topic>Female</topic><topic>Germany - epidemiology</topic><topic>Hospital Information Systems</topic><topic>Hospital Mortality</topic><topic>Hospitals, University - standards</topic><topic>Humans</topic><topic>intensive care</topic><topic>Intensive Care Units - standards</topic><topic>Length of Stay - statistics &amp; numerical data</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical Records Systems, Computerized</topic><topic>Odds Ratio</topic><topic>Outcome and Process Assessment (Health Care) - statistics &amp; numerical data</topic><topic>ROC Curve</topic><topic>Surgical Procedures, Operative - mortality</topic><topic>Surgical Procedures, Operative - standards</topic><topic>Surgical Wound Infection - drug therapy</topic><topic>Surgical Wound Infection - mortality</topic><topic>Surgical Wound Infection - prevention &amp; control</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hartmann, Bernd</creatorcontrib><creatorcontrib>Junger, Axel</creatorcontrib><creatorcontrib>Brammen, Dominik</creatorcontrib><creatorcontrib>Röhrig, Rainer</creatorcontrib><creatorcontrib>Klasen, Joachim</creatorcontrib><creatorcontrib>Quinzio, Lorenzo</creatorcontrib><creatorcontrib>Benson, Matthias</creatorcontrib><creatorcontrib>Hempelmann, Gunter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hartmann, Bernd</au><au>Junger, Axel</au><au>Brammen, Dominik</au><au>Röhrig, Rainer</au><au>Klasen, Joachim</au><au>Quinzio, Lorenzo</au><au>Benson, Matthias</au><au>Hempelmann, Gunter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours</atitle><jtitle>Clinical therapeutics</jtitle><addtitle>Clin Ther</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>26</volume><issue>6</issue><spage>915</spage><epage>924</epage><pages>915-924</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Background: A number of developments have been made in computerized patient data management systems (PDMSs), making them of interest to medical and nursing staff as a means of improving patient care. Objectives: The aim of this study was to assess the capability of a PDMS to record and provide drug-administration data and to investigate whether the PDMS may be used as a means of support for clinical audits and quality control. Furthermore, we assessed whether antibiotic therapy as a surrogate for infections correlates with hospital mortality in patients staying &gt;24 hours in a surgical intensive care unit (SICU). Methods: Because of its medical and economic importance in ICU treatment, we chose to use the field of antibiotic therapy as an example. A PDMS was used in a 14-bed SICU (Department of Anesthesiology, Intensive Care Medicine, and Pain Therapy, University Hospital Giessen, Giessen, Germany) to record relevant patient data, including therapeutic, diagnostic, and nursing actions. During a 15-month period (April 1, 2000 to June 30, 2001), antibiotic drug therapy was electronically analyzed and presented using the anatomic therapeutic chemical (ATC) category for antibacterials (ATC group, J01) with daily defined doses. Furthermore, the correlation of antibiotic therapy with patient outcome (hospital mortality) was tested using logistic regression analysis. Results: A total of 2053 patients were treated in the SICU. Of these, 58.0% (1190 patients) received antibiotics (4479 treatment days; 13,145 single doses). Cephalosporins (ATC category, J01DA) were used most frequently (1785 treatment days [39.9% of treatment days]), followed by combinations of penicillins with beta-lactam inhibitors (ATC category, J01CR; 1478 treatment days [33.0%]) and imidazole derivatives (ATC category, J01XD; 667 treatment days [14.9%]). The antibiotic therapy lasted &lt;3 days in 65.6% of cases. In 13.8% of cases, the treatment lasted &gt;1 week. A total of 36.7% of cases were treated with only 1 antibiotic agent, 14.1% were given a combination of 2, and 7.2% were given a combination of ≥3 antibiotic agents. Seven hundred twenty-six patients remained in the SICU for &gt;24 hours; 143 (19.7%) died during their hospital stay; 110 (15.2%) in the SICU. The duration of antibiotic therapy (odds ratio [OR], 1.46) and number of different antibiotic drugs used (OR, 2.15) significantly correlated with hospital mortality. Conclusions: Antibiotic therapy in a SICU can be assessed and analyzed in detail using a PDMS. Furthermore, in this study, the duration of antibiotic therapy and the number of antibiotic agents used correlated with hospital mortality. In further developing PDMSs, it is important for quality-assurance purposes to document the reasons for giving antibiotics and for changing prescriptions. It would also be helpful to integrate certain therapy standards and reminder functions for the duration of therapy in the PDMS.</abstract><cop>United States</cop><pub>EM Inc USA</pub><pmid>15262462</pmid><doi>10.1016/S0149-2918(04)90135-X</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0149-2918
ispartof Clinical therapeutics, 2004-06, Vol.26 (6), p.915-924
issn 0149-2918
1879-114X
language eng
recordid cdi_proquest_miscellaneous_66720494
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Anti-Bacterial Agents - classification
Anti-Bacterial Agents - therapeutic use
antibiotics
Bacterial Infections - drug therapy
Bacterial Infections - mortality
Bacterial Infections - prevention & control
computerized patient record
critical care
drug therapy
Drug Utilization Review - statistics & numerical data
Female
Germany - epidemiology
Hospital Information Systems
Hospital Mortality
Hospitals, University - standards
Humans
intensive care
Intensive Care Units - standards
Length of Stay - statistics & numerical data
Logistic Models
Male
Medical Records Systems, Computerized
Odds Ratio
Outcome and Process Assessment (Health Care) - statistics & numerical data
ROC Curve
Surgical Procedures, Operative - mortality
Surgical Procedures, Operative - standards
Surgical Wound Infection - drug therapy
Surgical Wound Infection - mortality
Surgical Wound Infection - prevention & control
Treatment Outcome
title Review of antibiotic drug use in a surgical ICU: Management with a patient data management system for additional outcome analysis in patients staying more than 24 hours
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T21%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20antibiotic%20drug%20use%20in%20a%20surgical%20ICU:%20Management%20with%20a%20patient%20data%20management%20system%20for%20additional%20outcome%20analysis%20in%20patients%20staying%20more%20than%2024%20hours&rft.jtitle=Clinical%20therapeutics&rft.au=Hartmann,%20Bernd&rft.date=2004-06-01&rft.volume=26&rft.issue=6&rft.spage=915&rft.epage=924&rft.pages=915-924&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/S0149-2918(04)90135-X&rft_dat=%3Cproquest_cross%3E66720494%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1032919246&rft_id=info:pmid/15262462&rft_els_id=S014929180490135X&rfr_iscdi=true